ImmunityBio, Inc.·4

Dec 16, 5:55 PM ET

Wendel Bruce 4

4 · ImmunityBio, Inc. · Filed Dec 16, 2025

Insider Transaction Report

Form 4
Period: 2025-12-12
Wendel Bruce
Director
Transactions
  • Award

    Stock Option (right to buy)

    2025-12-12+146,020146,020 total
    Exercise: $2.36Exp: 2035-12-12Common Stock (146,020 underlying)
Footnotes (1)
  • [F1]Subject to the reporting person's continuing to be a Service Provider (as defined in the 2025 Equity Incentive Plan) through each applicable vesting date, 48,673 of the shares subject to the award will vest on December 12, 2026, 48,673 of the shares subject to the award will vest on December 12, 2027 and 48,674 of the shares subject to the award will vest on December 12, 2028, such that the award will be fully vested on December 12, 2028; provided that, notwithstanding the foregoing, any unvested shares subject to the award will fully vest immediately prior to a Change in Control (as defined in the 2025 Equity Incentive Plan), subject to the reporting person continuing to be a Service Provider through the date of such Change in Control.

Documents

1 file
  • 4
    wk-form4_1765925747.xmlPrimary

    FORM 4